(1)
Uike, P.; Hiwarkar, P.; Malkar, V.; Aswalle, K. Profile of Multi Drug Resistant (MDR) and Rifampicin Resistant TB Patients Treated under Category IV of RNTCP. Int J Basic Clin Pharmacol 2017, 6, 784-787.